Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin

Cellular and Molecular Life Sciences

Volumn 62, Issue 11, 2005, Pages 1275-1282

  Mijatovic, S ^a   Maksimovic Ivanic, D ^a   Radovic, J ^a   Miljkovic, D ^a   Kaludjerovic, G N ^b   Sabo, T J ^b   Trajkovic, V ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Aloe emodin; Apoptosis; Cancer; Cisplatin; ERK; Necrosis

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALOE EMODIN; CISPLATIN; CRYSTAL VIOLET; DNA FRAGMENT; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLSERINE; PLATINUM DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; TETRACHLORO(O,O DIBUTYLETHYLENEDIAMINE N,N' DI 3 PROPANOATE)PLATINUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL ASSAY; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FIBROSARCOMA; FLOW CYTOMETRY; GLIOMA CELL; MOUSE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; RAT; TUMOR CELL; WESTERN BLOTTING;

ALOE; MURINAE;

EID: 21144443656     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-005-5041-3     Document Type: Article

References (46)

1. Galanski M., Arion V. B., Jakupec M. A. and Keppler B. K. (2003) Recent developments in the field of tumor-inhibiting metal complexes. Curr. Pharm. Des. 9: 2078-2089
2. Zhang C. X. and Lippard S. J. (2003) New metal complexes as potential therapeutics. Curr. Opin. Chem. Biol. 7: 481-489
3. Eastman A. (1987) The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol. Ther. 34: 155-166
4. Siddik Z. H. (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279
5. Chan T. C., Chang C. J., Koonchanok N. M. and Geahlen R. L. (1993) Selective inhibition of the growth of ras-transformed human bronchial epithelial cells by emodin, a protein-tyrosine kinase inhibitor. Biochem. Biophys. Res. Commun. 193: 1152-1158
6. Zhang L., Chang C. J., Bacus S. S. and Hung M. C. (1995) Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Cancer Res. 55: 3890-3896
7. Kuo Y. C., Sun C. M., Ou J. C. and Tsai W. J. (1997) A tumor cell growth inhibitor from Polygonum hypoleucum Ohwi. Life Sci. 61: 2335-2344
8. Lee H. Z. (2001) Effects and mechanisms of emodin on cell death in human lung squamous cell carcinoma. Br. J. Pharmacol. 134: 11-20
9. Chen Y. C., Shen S. C., Lee W. R., Hsu F. L. Lin H. Y., Ko C. H. et al. (2002) Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochem. Pharmacol. 64: 1713-1724
10. Zhang L., Lau Y. K., Xia W., Hortobagyi G. N. and Hung M. C. (1999) Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel. Clin. Cancer Res. 5: 343-353
11. Zhang L. and Hung M. C. (1996) Sensitization of HER-2/ neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin. Oncogene 12: 571-576
12. Lee H. Z., Hsu S. L., Liu M. C. and Wu C. H. (2001) Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma. Eur. J. Pharmacol. 431: 287-295
13. Kuo P. L., Lin T. C. and Lin C. C. (2002) The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sci. 71: 1879-1892
14. Yeh F. T., Wu C. H. and Lee H. Z. (2003) Signalling pathway for aloe-emodin-induced apoptosis in human H460 lung nonsmall carcinoma cell. Int. J. Cancer 106: 26-33
15. Mijatovic S., Maksimovic-Ivanic D., Radovic J., Miljkovic Dj., Harhaji Lj., Vuckovic O. et al. (2005) Anti-glioma action of aloe emodin: the role of ERK inhibition. Cell. Mol. Life Sci. 62: 589-598
16. Pecere T., Gazzola M. V., Mucignat C., Parolin C., Vecchia F. D., Cavaggioni A. et al. (2000) Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res. 60: 2800-2804
17. Chang L. C., Sheu H. M., Huang Y. S., Tsai T.R. and Kuo K. W. (1999) A novel function of emodin: enhancement of the nucleotide excision repair of UV- and cisplatin-induced DNA damage in human cells. Biochem. Pharmacol. 58: 49-57
18. Boreham C. J., Broomhead J. A. and Fairlie D. P. (1981) A platinum-195 and nitrogen-15 NMR study of the anticancer drug cis-diamminedichloroplatinum (II) and its hydrolysis and oligomerization products. Aust. J. Chem. 34: 659-664
19. Sabo T. J., Kaludjerovic G. N., Grguric-Sipka S. R., Heinemann F. W. and Trifunovic S. R. (2004) Complex compounds of platinum(IV) and O,O-dialkyl-ethylenediamine-N,N′-di-3-propanoate ligands: a structural evidence for geometry of hydrolytic product of some esters. Inorg. Chem. Commun. 7: 241-244
20. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63
21. Flick D. A. and Gifford G. E. (1984) Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods 68: 167-175
22. Decker T. and Lohmann-Matthes M. L. (1998) A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods. 115: 61-69
23. Versteeg H. H., Nijhuis E., Brink G. R. van den, Evertzen M., Pynaert G. N. Deventer S. J. van et al. (2000) A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein. Biochem. J. 350: 717-722
24. Hayakawa J., Ohmichi M., Kurachi H., Ikegami H., Kimura A., Matsuoka T. et al. (1999) Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. J. Biol. Chem. 274: 31648-31654
25. Hayakawa J., Mittal S., Wang Y., Korkmaz K. S., Adamson E., English C. et al. (2004) Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Mol. Cell. 16: 521-535
26. Kaludjerovic G. N., Miljkovic Dj., Momcilovic M., Djinovic V. M., Mostarica Stojkovic M., Sabo T. J. et al. (in press) Novel platinum(IV) complexes induce rapid tumor cell death in vitro. Int. J. Cancer
27. Dudley D. T., Pang L., Decker S. J., Bridges A. J. and Saltiel A. R. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci USA 92: 7686-7689
28. Wang X., Martindale J. L. and Holbrook N. J. (2000) Requirement for ERK activation in cisplatin-induced apoptosis. J. Biol. Chem. 275: 39435-39443
29. Park S. A., Park H. J., Lee B. I., Ahn Y. H., Kim S. U. and Choi K. S. (2001) Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells. Brain Res. Mol. Brain Res. 93: 18-26
30. Woessmann W., Chen X. and Borkhardt A. (2002) Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines. Cancer Chemother. Pharmacol. 50: 397-340
31. Schweyer S., Soruri A., Meschter O., Heintze A., Zschunke F., Miosge N. et al. (2004) Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation. Br. J. Cancer. 91: 589-598
32. Choi B. K., Choi C. H., Oh H. L. and Kim Y. K. (2004) Role of ERK activation in cisplatin-induced apoptosis in A172 human glioma cells. Neurotoxicology 25: 915-924
33. Persons D. L., Yazlovitskaya E. M., Cui W. and Pelling J. C. (1999) Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin. Cancer Res. 5: 1007-1014
34. Mandell J. W., Hussaini I. M., Zecevic M., Weber M. J. and VandenBerg S. R. (1998) In situ visualization of intratumor growth factor signalling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms. Am. J. Pathol. 153: 1411-1423
35. Santen R. J., Song R. X., McPherson R., Kumar R., Adam L., Jeng M. H. et al. (2002) The role of mitogen-activated protein (MAP) kinase in breast cancer. J. Steroid Biochem. Mol. Biol. 80: 239-256
36. Huang Q., Shen H. M. and Ong C. N. (2004) Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB. Biochem. Pharmacol. 68: 361-371
37. Gschwendt M., Kittstein W. and Marks F. (1991) Protein kinase C activation by phorbol esters: do cysteine-rich regions and pseudo-substrate motifs play a role? Trends Biochem. Sci. 16: 167-169
38. Schweyer S., Soruri A., Heintze A., Radzun H. J. and Fayyazi A. (2004) The role of reactive oxygen species in cisplatin-induced apoptosis in human malignant testicular germ cell lines. Int. J. Oncol. 25: 1671-1676
39. Malterud K. E., Farbrot T. L., Huse A. E. and Sund R. B. (1993) Antioxidant and radical scavenging effects of anthraquinones and anthrones. Pharmacology 47 (suppl 1): 77-85
40. Chang C. J., Ashendel C. L., Geahlen R. L., McLaughlin J. L. and Waters D. J. (1996) Oncogene signal transduction inhibitors from medicinal plants. In Vivo 10: 185-190
41. Mijatovic S., Maksimovic-Ivanic D., Radovic J., Popadic D., Momcilovic M., Harhaji Lj. et al. (2004) Aloe emodin prevents cytokine-induced tumor cell death: the inhibition of auto-toxic nitric oxide release as a potential mechanism. Cell. Mol. Life Sci. 61: 1805-1815
42. Fenig E., Nordenberg J., Beery E., Sulkes J. and Wasserman L. (2004) Combined effect of aloe-emodin and chemotherapeutic agents on the proliferation of an adherent variant cell line of Merkel cell carcinoma. Oncol. Rep. 11: 213-217
43. Townsend K. J., Trusty J. L., Traupman M. A., Eastman A. and Craig R. W. (1998) Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C. Oncogene 17: 1223-1234
44. Cui W., Yazlovitskaya E. M., Mayo M. S., Pelling J. C. and Persons D. L. (2000) Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal-regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines. Mol. Carcinog. 29: 219-228
45. Mandic A., Viktorsson K., Heiden T., Hansson J. and Shoshan M. C. (2001) The MEK1 inhibitor PD98059 sensitizes C8161 melanoma cells to cisplatin-induced apoptosis. Melanoma Res. 11: 11-19
46. Aoki K., Ogawa T., Ito Y. and Nakashima S. (2004) Cisplatin activates survival signals in UM-SCC-23 squamous cell carcinoma and these signal pathways are amplified in cisplatin-resistant squamous cell carcinoma. Oncol. Rep. 11: 375-379